CYREBRO’s AI-Native MDR Platform Earns Silver at the 2025 Globee Cybersecurity Awards
TEL AVIV, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- CYREBRO, the AI-native…
Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn’s and Colitis Organisation (ECCO)
February 18, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL…
Check Point Software Reports Fourth Quarter and 2024 Full Year Results
TEL AVIV, Israel, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Check Point® Software…
Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth
2024 Revenues of $16.5 billion reflect an increase of 6%, in local…
SciSparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for its Clinical Trial in Children with Autism Spectrum Disorder
TEL AVIV, Israel, Dec. 31, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq:…
Microtech Announces First Human Case of Implantable Microsensor for Heart Failure
TEL AVIV, Israel, Dec. 26, 2024 /PRNewswire/ -- Microtech, a wholly owned…
Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 23, 2024 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL…
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025
December 20, 2024 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL…
Seegnal Signs Agreement to Install the “Virtual Pharmacist” in a Network of 20 Hospitals in Poland
December 18, 2024 17:00 ET | Source: Seegnal eHealth Ltd. TEL AVIV,…
AU10TIX Expands Global Presence in Bengaluru to Support India’s Digital Identity Transformation
Dedicated Presence to Empower Local Businesses with AI-Driven Identity Verification Solutions, Enabling…